LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration

Leucine-rich a-2-glycoprotein 1 (LRG1) is a candidate therapeutic target for treating the neovascular form of age-related macular degeneration (nvAMD). In this study we examined the expression of LRG1 in eyes of nvAMD patients. Choroidal neovascular membranes (CNVMs) from patients who underwent subm...

Descripción completa

Detalles Bibliográficos
Autores principales: Mundo, Lucia, Tosi, Gian Marco, Lazzi, Stefano, Pertile, Grazia, Parolini, Barbara, Neri, Giovanni, Posarelli, Matteo, De Benedetto, Elena, Bacci, Tommaso, Silvestri, Ennio, Siciliano, Maria Chiara, Barbera, Stefano, Orlandini, Maurizio, Greenwood, John, Moss, Stephen E., Galvagni, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396268/
https://www.ncbi.nlm.nih.gov/pubmed/34445590
http://dx.doi.org/10.3390/ijms22168879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396268/
https://www.ncbi.nlm.nih.gov/pubmed/34445590
http://dx.doi.org/10.3390/ijms22168879

Ejemplares similares